Comparative effectiveness of six herbs in the management of glycemic status of type 2 diabetes mellitus patients: A systematic review and network meta-analysis of randomized controlled trials

被引:9
|
作者
Kumar, Subodh [1 ]
Sharma, Suresh K. [2 ]
Mudgal, Shiv Kumar [3 ]
Gaur, Rakhi [3 ]
Agarwal, Rajat [4 ]
Singh, Harminder [1 ]
Kalra, Sanjay [5 ,6 ]
机构
[1] All India Inst Med Sci, Dept Pharmacol, Deoghar, Jharkhand, India
[2] All India Inst Med Sci, Coll Nursing, Jodhpur, Rajasthan, India
[3] All India Inst Med Sci, Coll Nursing, Deoghar, Jharkhand, India
[4] All India Inst Med Sci, Dept Cardiothorac Surg, Deoghar, Jharkhand, India
[5] Bharti Hosp, Dept Endocrinol, Karnal, Haryana, India
[6] BRIDE, Karnal, Haryana, India
关键词
Glycemic status; Herbal formulations; Network meta-analysis; Type 2 diabetes mellitus; FASTING BLOOD-GLUCOSE; DOUBLE-BLIND; LIPID PROFILE; NANO-CURCUMIN; SAFFRON SUPPLEMENTATION; INFLAMMATORY MARKERS; CINNAMON EXTRACT; HEMOGLOBIN A1C; PLACEBO; MEDICINE;
D O I
10.1016/j.dsx.2023.102826
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: There are several herbal formulations for type 2 diabetes (T2D), but many of them have never been directly compared to establish the most effective methods. Therefore, the present systematic review and network meta-analysis aimed to compare and rank the effects of herbal formulations by combining direct and indirect evidence on the management of type 2 diabetes.Methods: From five electronic databases, relevant studies on the effectiveness of herbal formulations for glycemic status for people with type 2 diabetes were retrieved. Only randomized controlled trials that were published in English and looked at how herbal formulations affected adults' (>18-year-old) glycemic levels were included. A systematic review and network meta-analysis design with the random-effects model was used.Results: A total of 44 trials included 3130 participants on six herbs were included in the final analysis. Apple cider vinegar (ACV) (standardized mean difference (SMD) = -28.99), cinnamon (-9.73), curcumin (-13.15), and fenugreek (-19.64) significantly reduced fasting blood glucose (FBG) compared with placebo (all p < 0.05). Notably, only ACV (SMD = -2.10) and fenugreek seeds (0.84) were found significantly effective in reducing HbA1C. ACV was most effective herb to reduce FBG comparison with other herbs.Conclusions: Several herbs could be considered as a valuable adjuvant therapy regarding glycemic control of type 2 diabetes patients. Health professionals should be encouraged to incorporate these herbs for the management of type 2 diabetes as part of their standard care.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] The effect of subcutaneous Lixisenatide on weight loss in patients with type 2 Diabetes Mellitus: Systematic review and Meta-Analysis of randomized controlled trials
    Sheng, Lei
    Deng, Meixian
    Li, Xin
    Wan, Huan
    Lei, Changjiang
    Prabahar, Kousalya
    Hernandez-Wolters, Benjamin
    Kord-Varkaneh, Hamed
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 210
  • [42] The effect of ginger supplementation on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials
    Ebrahimzadeh, Armin
    Ebrahimzadeh, Anahita
    Mirghazanfari, Sayid Mahdi
    Hazrati, Ebrahim
    Hadi, Saeid
    Milajerdi, Alireza
    COMPLEMENTARY THERAPIES IN MEDICINE, 2022, 65
  • [43] Probiotics and synbiotics for glycemic control in diabetes: A systematic review and meta-analysis of randomized controlled trials
    Baroni, Irene
    Fabrizi, Diletta
    Luciani, Michela
    Magon, Arianna
    Conte, Gianluca
    De Angeli, Giada
    Paglione, Giulia
    Ausili, Davide
    Caruso, Rosario
    CLINICAL NUTRITION, 2024, 43 (04) : 1041 - 1061
  • [44] Management of Frailty: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials
    Negm, Ahmed M.
    Kennedy, Courtney C.
    Thabane, Lehana
    Veroniki, Areti-Angeliki
    Adachi, Jonathan D.
    Richardson, Julie
    Cameron, Ian D.
    Giangregorio, Aidan
    Petropoulou, Maria
    Alsaad, Saad M.
    Alzahrani, Jamaan
    Maaz, Muhammad
    Ahmed, Muhammad M.
    Kim, Eileen
    Tehfe, Hadi
    Dima, Robert
    Sabanayagam, Kalyani
    Hewston, Patricia
    Abu Alrob, Hajar
    Papaioannou, Alexandra
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2019, 20 (10) : 1190 - 1198
  • [45] Telemedicine for the Management of Glycemic Control and Clinical Outcomes of Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Studies
    Lee, Shaun W. H.
    Ooi, Leanne
    Lai, Yin K.
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [46] Effectiveness of Internet-Based Interventions on Glycemic Control in Patients With Type 2 Diabetes: Meta-Analysis of Randomized Controlled Trials
    Shen, Ying
    Wang, Fengbin
    Zhang, Xing
    Zhu, Xiaorou
    Sun, Qiudan
    Fisher, Edwin
    Sun, Xinying
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2018, 20 (05)
  • [47] Effects of Soy Isoflavones on Glycemic Control and Lipid Profile in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Baranska, Agnieszka
    Blaszczuk, Agata
    Polz-Dacewicz, Malgorzata
    Kanadys, Wieslaw
    Malm, Maria
    Janiszewska, Mariola
    Jedrych, Marian
    NUTRIENTS, 2021, 13 (06)
  • [48] The Effect of Physical Activity on Glycemic Variability in Patients With Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Zhu, Xingyun
    Zhao, Lina
    Chen, Jing
    Lin, Chu
    Lv, Fang
    Hu, Suiyuan
    Cai, Xiaoling
    Zhang, Li
    Ji, Linong
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [49] Glycemic control and the incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of randomized controlled trials
    Lin, Chu
    Cai, Xiaoling
    Yang, Wenjia
    Lv, Fang
    Nie, Lin
    Ji, Linong
    ENDOCRINE, 2020, 70 (02) : 232 - 242
  • [50] Glycemic control and the incidence of neoplasm in patients with type 2 diabetes: a meta-analysis of randomized controlled trials
    Chu Lin
    Xiaoling Cai
    Wenjia Yang
    Fang Lv
    Lin Nie
    Linong Ji
    Endocrine, 2020, 70 : 232 - 242